The E318K mutation, previously linked to melanoma and renal cell carcinoma, enhances MITF transcriptional activity and may contribute to aggressive disease behavior.<h4>Conclusion</h4>This case expands current understanding of MITF in prostate cancer and raises important questions regarding its prognostic and therapeutic significance. Here, MITF is linked to prostate cancer.